8-KLeadership ChangesExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Executive Changes (Oct 21, 2011)

Filed October 21, 2011For Securities:BMYCELG-RIBMYMP

Summary

This Form 8-K filing by Bristol-Myers Squibb Company (BMY) primarily reports the retirement of Senior Vice President, Commercial Operations and President, U.S., Japan and Intercontinental, Anthony C. Hooper, effective October 25, 2011. While not a financial event, this executive departure signifies a leadership change within a key operational segment of the company, which could have implications for commercial strategy and execution in significant global markets. Investors should monitor any subsequent announcements regarding the transition of Mr. Hooper's responsibilities and any new appointments to ensure continuity and assess the impact on the company's commercial operations and future performance. The filing also notes the inclusion of a press release dated October 19, 2011, as an exhibit, which may contain further details related to this or other company matters.

Key Highlights

  • 1Anthony C. Hooper, Senior Vice President, Commercial Operations and President, U.S., Japan and Intercontinental, announced his retirement.
  • 2Mr. Hooper's retirement is effective October 25, 2011.
  • 3The departure is reported under Item 5.02 of the 8-K, concerning departures of officers.
  • 4This filing does not contain material financial updates or disclosures.
  • 5A press release dated October 19, 2011, is included as Exhibit 99.1, potentially providing more context.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report the upcoming retirement of a key executive, Anthony C. Hooper, who holds significant commercial leadership positions within Bristol-Myers Squibb.

No, this filing does not disclose any specific financial performance information, changes in financial condition, or material business developments. It is focused on an executive change.

Anthony C. Hooper was the Senior Vice President of Commercial Operations and President of U.S., Japan, and Intercontinental operations for Bristol-Myers Squibb. His retirement marks the departure of a senior leader responsible for substantial global commercial activities.

The filing mentions Exhibit 99.1, which is a press release dated October 19, 2011. This press release may offer additional details or context regarding Mr. Hooper's retirement or other company matters.